EXACT Sciences

Yahoo Finance • 6 days ago

Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc

This article first appeared on GuruFocus. Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2025, shedding light on its strategic... Full story

Yahoo Finance • 6 days ago

Catalyst Watch: Santa Claus Effect, M&A votes on Electronic Arts and TrueCar, index shuffling

[Futuristic display screen with a bar graph and colorful spreadsheet financial data] matejmo Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that... Full story

Yahoo Finance • 8 days ago

How The Abbott Takeover Is Rewriting Exact Sciences Story And Valuation

Exact Sciences stock now sits at the center of a tightening deal spread, with our fair value estimate holding steady near $103.67 per share. This closely tracks the proposed $105 takeout price even as the discount rate edges up to 7.27 and... Full story

Yahoo Finance • 17 days ago

Validea Detailed Fundamental Analysis - EXAS

Below is Validea's guru fundamental report for EXACT SCIENCES CORP (EXAS). Of the 22 guru strategies we follow, EXAS rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model l... Full story

Yahoo Finance • 19 days ago

Assessing Exact Sciences After 77.5% YTD Surge and Abbott Deal Outlook

If you have been wondering whether Exact Sciences is still worth buying after its huge run, you are not alone. This breakdown is designed to help you decide if the current price makes sense. The stock has climbed to around $101.06, logging... Full story

Yahoo Finance • 21 days ago

Bio-Techne Corporation (TECH): A Bull Case Theory

We came across a bullish thesis on Bio-Techne Corporation on Valueinvestorsclub.com by rab. In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation's share was trading at $64.63 as of November 26th. TECH’s trai... Full story

Yahoo Finance • 23 days ago

Here's Why Grail Soared, Again, in November

Key Points Early cancer detection is highly beneficial to sufferers, and Grail's Galleri test offers a solution. The company is the leader in the race for FDA approval, but it could benefit from being part of a larger company. Commercial... Full story

Yahoo Finance • 24 days ago

Cathie Wood dumps $8.46 million in software giant

Cathie Wood’s never been shy in rebalancing aggressively when she feels the market’s mispricing innovation, and her latest trades fit that description perfectly. The ARK Invest boss dumped nearly 855,000 GitLab (GTLB) stock in just a few... Full story

Yahoo Finance • 24 days ago

Cathie Wood's Ark Invest weekly recap: Boosts AI and Crypto Bets, Trims Palantir, GitLab, and AMD

[Investment. Businessman using laptop and analyzing data with investment growth on stock markets, startups, real estate, technology, and financial trends on global network.] Harsa Maduranga/iStock via Getty Images Cathie Wood’s ARK Invest... Full story

Yahoo Finance • 26 days ago

UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition

Abbott Laboratories (NYSE:ABT) ranks among the best slow growth stocks to invest in. UBS reaffirmed its Buy rating and $158 price target for Abbott Laboratories (NYSE:ABT) on November 21 in response to the company’s agreed acquisition of E... Full story

Yahoo Finance • 28 days ago

Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 28 days ago

HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN

NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), who has recovered millions of dollars for shareholders... Full story

Yahoo Finance • 30 days ago

Brinker upgraded, Coinbase downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: UBS upgraded Applied Materials(AMAT) t... Full story

Yahoo Finance • 30 days ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More

Chaay_Tee / iStock via Getty Images Quick Read The markets stormed back on Monday after a late Friday reversal, which was a big positive for traders. All the major indices rose on Monday, and concerns about a big Thanksgiving sell-off di... Full story

Yahoo Finance • last month

Booking, Carvana upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Wedbush upgraded Carvana (CVNA) to Out... Full story

Yahoo Finance • last month

EXAS Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Exact Sciences to Abbott Laboratories

MONSEY, N.Y., Nov. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Exact Sciences Corporation (Nasdaq: EXAS) (“Exact Sciences”) to Abbott Laboratories for $105.00 per... Full story

Yahoo Finance • last month

Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More

mezzotint / Shutterstock.com Quick Read With limited economic data, the Thanksgiving holiday on Thursday, and an early close on Friday, many on Wall Street expect a quieter week than the preceding one. There appears to be a tug-of-war no... Full story

Yahoo Finance • last month

Jim Cramer on Abbott: “I Think It’s a Terrific Time to Do Some Buying”

Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently offered insights on. Cramer highlighted the company’s acquisition of Exact Sciences and said that it complements Abbott’s diagnostic business, as he remarked: “This m... Full story

Yahoo Finance • last month

Cathie Wood buys the dip in Nvidia-backed stock

In no time, CoreWeave (CRWV) has become one of the most talked-about names in AI, but the going’s been rough of late. The Nvidia (NVDA)-backed cloud infrastructure business has just slashed its sales outlook, sending its stock into a stee... Full story

Yahoo Finance • last month

Notable healthcare headlines for the week: Abbott, Medtronic, Merck and J&J in focus

Wall Street staged a rebound on Friday, closing the session in positive territory after a turbulent, tech-driven downturn rattled the Nasdaq Composite just a day earlier. Friday's market boost was supported by reports that the Trump admin... Full story